Views: 1,420 | Downloads:
22
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
Comparison of Clinical Features and Survival of Patients with Hepatitis B-and Hepatitis C-Associated Hepatocellular Carcinoma in Thailand
Tangkijvanich P 
,
Suwangool P ,
V
,
Suwangool P ,
V PISIT TANGKIJVANICH, MD*,
PONGSPEERA SUWANGOOL, MD**,
V AROCHA MAHACHAI, MD***
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are leading causes hepatocellular carci-
noma (HCC) worldwide. The aim of this study was to determine whether differences do exist between
HBV-and HCV-associated HCC in terms of clinical, pathologic features and prognosis among Thai
patients. The authors retrospectively reviewed the clinical data of 188 patients with pathologically
proven HCC, who were admitted to Chulalongkom Hospital between January 1997 and December
1999. Of these cases, there were 105 patients (55.9%) with hepatitis B surface antigen (HbsAg) posi-
tive, 19 patients ( 10.1%) with anti-HCV positive, and 2 patients ( 1.0%) with both markers positive.
The authors found that the mean age of patients with HBsAg positive was significantly lower than
that of anti-HCV positive (49.2
เธ‘
12.7 and 58.3
เธ‘
8.9 years, respectively, p
=
0.003). In contrast, the
mean serum alpha-fetoprotein level of HBsAg positive group was significantly higher than that of anti-
HCV positive group (48,583.6
เธ‘
109,494.1 and 2,022.7
เธ‘
4,869.1 IU/ml, respectively, p
=
0.001).
However, there was no difference between the two groups in terms of the severity of underlying liver
disease, tumor histology and morphology, clinical staging, and the overall survival rate of the patients.
The authors concluded that, among Thai populatons, the majority of clinical features and survival of
HBV-associated HCC did not differ from those with HCV-associated HCC.
Key word : Hepatocellular carcinoma, Hepatitis B, Hepatitis C, Alpha-fetoprotein, Thailand
PONGSPEERA SUWANGOOL, MD**,
V AROCHA MAHACHAI, MD***
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are leading causes hepatocellular carci-
noma (HCC) worldwide. The aim of this study was to determine whether differences do exist between
HBV-and HCV-associated HCC in terms of clinical, pathologic features and prognosis among Thai
patients. The authors retrospectively reviewed the clinical data of 188 patients with pathologically
proven HCC, who were admitted to Chulalongkom Hospital between January 1997 and December
1999. Of these cases, there were 105 patients (55.9%) with hepatitis B surface antigen (HbsAg) posi-
tive, 19 patients ( 10.1%) with anti-HCV positive, and 2 patients ( 1.0%) with both markers positive.
The authors found that the mean age of patients with HBsAg positive was significantly lower than
that of anti-HCV positive (49.2
เธ‘
12.7 and 58.3
เธ‘
8.9 years, respectively, p
=
0.003). In contrast, the
mean serum alpha-fetoprotein level of HBsAg positive group was significantly higher than that of anti-
HCV positive group (48,583.6
เธ‘
109,494.1 and 2,022.7
เธ‘
4,869.1 IU/ml, respectively, p
=
0.001).
However, there was no difference between the two groups in terms of the severity of underlying liver
disease, tumor histology and morphology, clinical staging, and the overall survival rate of the patients.
The authors concluded that, among Thai populatons, the majority of clinical features and survival of
HBV-associated HCC did not differ from those with HCV-associated HCC.
Key word : Hepatocellular carcinoma, Hepatitis B, Hepatitis C, Alpha-fetoprotein, Thailand
Download:
PDF